Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [843]

Big data, machine learning and drug discovery in oncology

Prof Bissan Al-Lazikani - Institute of Cancer Research, London, UK

Big data, machine learning and drug discovery in oncology ( Prof Bissan Al-Lazikani - Institute of Cancer Research, London, UK )

SABCS 2020: Conference roundup

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

SABCS 2020: Conference roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL...

Dr Liora Schultz - Stanford University School of Medicine, Palo Alto, USA

PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL after commercial tisagenlecleucel ( Dr Liora Schultz - Stanford University School of Medicine, Palo Alto, USA )

Researchers trace the origin of blood cancer to early childhood, decades before...

Dr Jyoti Nangalia - University of Cambridge, Cambridge, UK

Researchers trace the origin of blood cancer to early childhood, decades before diagnosis ( Dr Jyoti Nangalia - University of Cambridge, Cambridge, UK )

Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by...

Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA

$Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA ( Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA )$

Circulating tumour cell dynamics as a predictor for treatment response and...

Prof Wolfgang Janni - Ulm University, Ulm, Germany

Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients ( Prof Wolfgang Janni - Ulm University, Ulm, Germany )

ASCENT: A phase II trial of induction, consolidation and maintenance in...

Prof Andrzej Jakubowiak - University of Chicago, Chicago, USA

ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM ( Prof Andrzej Jakubowiak - University of Chicago, Chicago, USA )

Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve...

Dr Jacqueline Garcia - Dana-Farber Cancer Institute, Boston, USA

Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings ( Dr Jacqueline Garcia - Dana-Farber Cancer Institute, Boston, USA )

Treating acute leukaemias of ambiguous lineage

Dr Lindsey Montefiori - Department of Pathology, St. Jude Children's Research...

Treating acute leukaemias of ambiguous lineage ( Dr Lindsey Montefiori - Department of Pathology, St. Jude Children's Research Hospital, USA )

First-in-class STAMP inhibitor asciminib in patients with CML harbouring the...

Dr Jorge Cortes - Augusta University, Augusta, USA

First-in-class STAMP inhibitor asciminib in patients with CML harbouring the T315I mutation ( Dr Jorge Cortes - Augusta University, Augusta, USA )

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D)...

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

Bosutinib versus imatinib for newly diagnosed chronic phase CML: BFOREfinal 5...

Prof Tim Brümmendorf - RWTH Aachen University, Aachen, Germany

Bosutinib versus imatinib for newly diagnosed chronic phase CML: BFOREfinal 5-year results ( Prof Tim Brümmendorf - RWTH Aachen University, Aachen, Germany )

More from ecancer